Astrana Health Inc (ASTH)vsUniversal Health Services Inc (UHS)
ASTH
Astrana Health Inc
$37.98
-0.13%
HEALTHCARE · Cap: $1.89B
UHS
Universal Health Services Inc
$174.83
+1.22%
HEALTHCARE · Cap: $10.13B
Smart Verdict
WallStSmart Research — data-driven comparison
Universal Health Services Inc generates 371% more annual revenue ($18.11B vs $3.84B). UHS leads profitability with a 8.4% profit margin vs 1.1%. UHS trades at a lower P/E of 7.0x. UHS earns a higher WallStSmart Score of 72/100 (B).
ASTH
Buy56
out of 100
Grade: C
UHS
Strong Buy72
out of 100
Grade: B
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for ASTH.
Margin of Safety
-24.0%
Fair Value
$186.49
Current Price
$174.83
$11.66 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 48.5% year-over-year
Earnings expanding 110.5% YoY
Reasonable price relative to book value
Attractively priced relative to earnings
Reasonable price relative to book value
Every $100 of equity generates 20 in profit
Areas to Watch
Smaller company, higher risk/reward
ROE of 3.8% — below average capital efficiency
1.1% margin — thin
Operating margin of 3.5%
No major concerns identified
Comparative Analysis Report
WallStSmart ResearchBull Case : ASTH
The strongest argument for ASTH centers on Revenue Growth, EPS Growth, Price/Book. Revenue growth of 48.5% demonstrates continued momentum.
Bull Case : UHS
The strongest argument for UHS centers on P/E Ratio, Price/Book, Return on Equity. PEG of 1.14 suggests the stock is reasonably priced for its growth.
Bear Case : ASTH
The primary concerns for ASTH are Market Cap, Return on Equity, Profit Margin. A P/E of 46.4x leaves little room for execution misses. Thin 1.1% margins leave little buffer for downturns.
Bear Case : UHS
No major red flags identified for UHS, but monitor valuation.
Key Dynamics to Monitor
ASTH profiles as a hypergrowth stock while UHS is a value play — different risk/reward profiles.
UHS carries more volatility with a beta of 1.06 — expect wider price swings.
ASTH is growing revenue faster at 48.5% — sustainability is the question.
UHS generates stronger free cash flow (216M), providing more financial flexibility.
Bottom Line
UHS scores higher overall (72/100 vs 56/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Astrana Health Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. The company is headquartered in Alhambra, California.
Universal Health Services Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?